institucionalizado. Rev Esp Gerontol 2004; 39:19-24.
8. Fiolavá D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, et al. ADHOC Project rescarch Group.Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293:1348-58.
9. Barry PJ, O´Keefe, O´Connor KA, O´Manhony D. Inappropriate prescribing in the erderly: A comparison of the Beers criteria and the improved prescribing in the erderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 2006; 31:617-26.
10. Liso A, Fernández V, Izuel-Rami M. Aplicación de los criterios Beers al ingreso en dos servicios de Medicina Interna. Atención Farmacéutica. 2008; 10 (5): 285-93.
11. Jano E, Aparasu R. Health care, outcomes associated with Beers ´Criteria, A Systematic Review. Ann Pharmacother 2007; 41:438-48.
12. Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate medication use in community residing older persons. Arch Intern Med.1994; 154:2195–200.
13. Zhan C, Sangl J, Bierman AS, Miller M R, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly. Findings from the 1996 Medical Expenditure Panel Survey.JAMA. 2001; 286: 2823–9.
14. Comité de Consenso. Tercer Consenso de Granada sobre Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos asociados a la Medicación (RNM). Ars Pharm. 2007; 48 (1): 5-17.
15. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, Francis SD, Branch LG, Lindblad CI, Artz M, Weinberger M, Feussner JR, Cohen HJ. Effectiveness of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. American Journal of Medicine 2004; 116:394-401.
16. Gutiérrez Aranda L. Registros e Indicadores de Calidad Asistencial. Desarrollo del Documento de Consenso sobre Atención Farmacéutica. Tesis en Opción al Título de Doctor en Ciencias. Universidad de Granada. 2006.
17. Barroso A. Aproximación a un Procedimiento Normalizado de Trabajo para realizar Seguimiento Farmacoterapéutico al adulto mayor. [Tesis en Opción al Título de Licenciada en Ciencias Farmacéuticas]. Departamento de Farmacia: Universidad de Oriente; Cuba. 2014.
18. Blasco Patiño F, Martínez López de Letona J, Villares P, Jiménez AI. El paciente anciano polimedicado: efectos sobre su salud y sobre el sistema sanitario. Inf Ter Sist Nac Salud. 2005; 29:152-62.
19. Llanes Betancourt C. Evaluación funcional y anciano frágil. Rev Cubana Enfermer. 2008 [citado 2 Sep 2012];24(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03192008000200005&lng=es
20. García M., Suárez R., Sánchez ME. Comorbilidad, estado funcional y terapéutica farmacológica en pacientes geriátricos. Rev Cubana Med Gen Integr 2012; 28 (4). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252012000400008&script=sci_arttext
21. Fick DM, Semla T, Beizer J, Brandt N, Dombrowski R, Flanagan N, et al. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc.2012; 60(4):616-31.
22. Gallagher P, Ryan C, Byrne S, Kennedy J, O’ Mahony D: STOPP (Screening Tool of Older Person’s Prescription) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.
23. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 27 (suppl 1): S79–S83. Also available at: http://care.diabetesjournals.org/cgi/reprint/27/suppl_1/s79.pdf
24. National Collaborating Centre for Chronic Conditions/NICE. Type 2 diabetes: the management of type 2 diabetes (issued May 2008). Available at: http://www.nice.org.uk/nicemedia/pdf/ CG66NICEGuideline.pdf.
25. Miguel F, García F, Montero MJ. Tratamiento de la hipertensión arterial en los diabéticos: una revisión crítica. SEMERGEN. 2007; 33:241-9.
26. García M., Abreu I, Ruíz AK., Espinosa J., Salinas TM. Prescripción farmacológica en ancianos hipertensos hospitalizados. Rev Cubana Farm 2013; 47 (4) disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152013000400007.
27. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (suppl 5): v1–v52. Also available at: http://heart.bmj.com/cgi/reprint/91/suppl_5/v1.
28. Juul-Möller S, et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340: 1421–5.
29. The Medical Research Council’s General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998; 351: 233–41.
30. Hansson L, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755–62.
31. Collaborative Group of the Primary Prevention Project. Lowdose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89–95.
32. Nicolucci A. Aspirin for Primary Prevention of Cardiovascular Events in Diabetes: Still an Open Question. JAMA. 2008; 300:2180-1.
33. American Diabetes Association. Standards of Medical Care in Diabetes 2009. Diabetes Care. 2009; 32Supl1:s13-s61.
34. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–65.
35. Delgado E, Muñoz M, Montero B, Sánchez C, Gallagher P y Cruz-Jentoft A. Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Rev Esp Geriatr Gerontol. 2009; 44(5):273–279.
36. Centro de Atención al Diabético. Instituto Nacional de Endocrinología. Guía cubana de práctica clínica basada en la evidencia Diabetes mellitus tipo 2. La Habana. Cuba. 2010; 47-50.
37. Holt S, Schmiedl S, Thurmann PA: Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107(31–32): 543–51.
38. Fundamentos de la atención geriátrica [editorial]. En: Beers MH, Berkow R, editores. The Manual Merck de Geriatría. 2ª ed.. Editorial Elservier. (versión en CD-ROM); 2001.